CCL2 and Patent ductus arteriosus: As recent studies have highlighted CAF heterogeneity in PDA (27, 32, 35, 36), we further dissected CCL2 secretion from 2 prominent CAF populations, myCAFs and inflammatory CAF (iCAFs), that we generated from KPC tumors as described previously (35).